Veradigm to Release Business Update June 23rd and Host Investor Call June 24th
Veradigm ® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a business update after the close of regular stock market hours on June 23, 2025. Veradigm management plans to host an investor conference call and webcast the Company's update at 8:00 a.m. Eastern Time on June 24, 2025.
Update Call Details
Veradigm plans to distribute an announcement promptly after the close of regular stock market hours on Monday, June 23, 2025. The announcement will also be available at Veradigm investor relations website.
To listen to the conference call, participants may log onto the Veradigm investor relations website. Participants also may access the conference call by dialing 877-405-1224 or 201-389-0848 and requesting Conference ID #13754301.
A replay of the call will be available for a period of one year on the Veradigm investor relations website.
About Veradigm®
Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube.
© 2025 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250618572168/en/
CONTACT: Investors:
Jenny Gelinas
312-506-1237
[email protected]:
Amanda Cohen
412-919-2417
[email protected]
KEYWORD: UNITED STATES NORTH AMERICA ILLINOIS
INDUSTRY KEYWORD: TECHNOLOGY HEALTH TECHNOLOGY PROFESSIONAL SERVICES SOFTWARE PRACTICE MANAGEMENT HEALTH DATA ANALYTICS GENERAL HEALTH DATA MANAGEMENT
SOURCE: Veradigm
Copyright Business Wire 2025.
PUB: 06/18/2025 05:27 PM/DISC: 06/18/2025 05:25 PM
http://www.businesswire.com/news/home/20250618572168/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Integra Resources Corp. (ITRG) Reports Strong Initial Results From 2025 Resource Growth Dilling Program in Nevada; H.C. Wainwright Maintains ‘Buy' Rating
Integra Resources Corp. (NYSE:ITRG) is one of the . A close-up of a technician using advanced geological-surveying equipment, evaluating a gold deposit. On August 5, 2025, Integra Resources Corp. (NYSE:ITRG) reported strong initial results from its 2025 resource growth drilling program at Florida Canyon Mine in Nevada. The program revealed broad, consistent near-surface oxide gold intercepts at the high-priority North Dump and Inter-Pit areas, with several exceeding current cut-off grades. Building on this momentum, the company expanded the program from 10,000 meters to 16,000 meters, aiming for accelerated resource growth and potential mine life extensions. Meanwhile, Integra Resources Corp. (NYSE:ITRG) reported Q2 2025 results on August 13, 2025. The mine recorded an output of 18,086 ounces of gold, meeting expectations and generating cash flow to support a planned $55 million reinvestment in Florida Canyon in 2025. Ahead of these developments, on July 18, 2025, H.C. Wainwright raised its price target to $3.25 from $2.75 with a 'Buy' rating. Integra Resources Corp. (NYSE:ITRG) is a growing precious metal producer in the Great Basin, Nevada, U.S. It is included in our list of the Best Penny Stocks. While we acknowledge the potential of ITRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Oil Refinery Stocks to Buy Right Now and 7 Best Potash Stocks to Buy According to Analysts. Disclosure: None. Sign in to access your portfolio
Yahoo
9 minutes ago
- Yahoo
Mizuho Reduces PT on PayPal Holdings, Inc. (PYPL)
With strong hedge fund interest and a low price-to-earnings ratio, PayPal Holdings, Inc. (NASDAQ:PYPL) secures a place on our list of the . Following the company's Q2 earnings release, Mizuho reduced its price target on PayPal Holdings, Inc. (NASDAQ:PYPL) from $87 to $84 on July 30, 2025. The analyst attributed the price revision to a slight dip in branded checkout growth and softer-than-expected transaction margin dollar guidance for the second half of 2025. Meanwhile, the company's core PayPal button business delivered strong performance when 'Buy Now Pay Later' and 'Pay with Venmo' segments are included. The latter segment is estimated to deliver 1.5 times the company-wide transaction margin. Furthermore, Barclays maintained its 'Buy' rating on PayPal Holdings, Inc. (NASDAQ:PYPL) on July 30 with a $90 target, and Needham maintained a 'Hold' rating the same day. Needham cited short-term e-commerce headwinds and modest EPS growth expectations. With its global technology platform, PayPal Holdings, Inc. (NASDAQ:PYPL) allows consumers to send, receive, and manage digital payments through multiple funding sources and channels. It is included in our list of the most undervalued value stocks to buy. While we acknowledge the potential of PYPL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.
Yahoo
9 minutes ago
- Yahoo
Wells Fargo Reaffirms ‘Buy' Rating on Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific Inc. (NYSE:TMO) is included in our list of the . A scientist performing a blood test on a patient using life sciences tools & services. Backed by the company's strong momentum across several key business segments, Wells Fargo reaffirmed its 'Buy' rating on Thermo Fisher Scientific Inc. (NYSE:TMO) on July 28, 2025. For Q2 2025, the company recorded strong growth across its Pharma Services, Bioproduction, and the Research/Safety Channel segments. The Research/Safety Channel segment saw TMO outperform its competitors, such as Avantor, with strong market share gains. The analyst acknowledged softness in the Analytical Instruments segment; however, the quarter's overall strong performance fueled optimism. Looking ahead, the analyst believes Thermo Fisher Scientific Inc. (NYSE:TMO)'s diversified portfolio and increasing market share will drive its growth. Thermo Fisher Scientific Inc. (NYSE:TMO) delivers life science solutions, alongside analytical instruments, specialty diagnostics, and laboratory products. It is included in our list of the Best Rebound Stocks To Buy. While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks. Disclosure: None. Sign in to access your portfolio
